Bluejay Diagnostics, Inc. (BJDX)
USD 3.25
(-12.16%)
USD 3.25
(-12.16%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 10.31 Million USD | 1.75% |
| 2022 | 9.36 Million USD | 196.87% |
| 2021 | 3.15 Million USD | 163.72% |
| 2020 | 1.19 Million USD | -26.67% |
| 2019 | 1.63 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.84 Million USD | -22.42% |
| 2024 Q1 | 2.37 Million USD | 1.86% |
| 2023 Q2 | 2.9 Million USD | 8.36% |
| 2023 FY | 9.53 Million USD | 1.75% |
| 2023 Q4 | 2.33 Million USD | -0.46% |
| 2023 Q3 | 2.34 Million USD | -19.37% |
| 2023 Q1 | 2.67 Million USD | 9.21% |
| 2022 Q2 | 2.03 Million USD | -1.63% |
| 2022 Q1 | 2.06 Million USD | 50.65% |
| 2022 FY | 9.36 Million USD | 196.87% |
| 2022 Q4 | 2.45 Million USD | -12.69% |
| 2022 Q3 | 2.81 Million USD | 38.12% |
| 2021 Q2 | 591.07 Thousand USD | 153.46% |
| 2021 Q4 | 1.37 Million USD | 43.31% |
| 2021 Q3 | 957.98 Thousand USD | 62.08% |
| 2021 Q1 | 233.19 Thousand USD | -59.92% |
| 2021 FY | 3.15 Million USD | 163.72% |
| 2020 Q1 | 226.27 Thousand USD | 0.0% |
| 2020 Q4 | 581.77 Thousand USD | 292.65% |
| 2020 Q3 | 148.16 Thousand USD | -34.52% |
| 2020 Q2 | 226.27 Thousand USD | 0.0% |
| 2020 FY | 1.19 Million USD | -26.67% |
| 2019 FY | 1.63 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | 8.132% |
| Cerus Corporation | 143.15 Million USD | 92.797% |
| OrthoPediatrics Corp. | 137.01 Million USD | 92.475% |
| PetVivo Holdings, Inc. | 11.36 Million USD | 9.239% |
| Talis Biomedical Corporation | 67.18 Million USD | 84.653% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 58.666% |
| Inogen, Inc. | 236.08 Million USD | 95.632% |
| Spectral AI, Inc. | 20.86 Million USD | 50.579% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 81.586% |
| CVRx, Inc. | 76.14 Million USD | 86.458% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -192.268% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | 17.438% |
| Orthofix Medical Inc. | 667.42 Million USD | 98.455% |
| Venus Concept Inc. | 80.47 Million USD | 87.187% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 81.775% |
| Bioventus Inc. | 409.91 Million USD | 97.485% |
| BrainsWay Ltd. | 28.01 Million USD | 63.198% |
| Envoy Medical, Inc. | 17.89 Million USD | 42.389% |
| electroCore, Inc. | 32.03 Million USD | 67.809% |
| IceCure Medical Ltd | 16.87 Million USD | 38.9% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 75.699% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 41.523% |
| MaxCyte, Inc. | 84.84 Million USD | 87.847% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | 16.924% |
| Nexalin Technology, Inc. | 5.78 Million USD | -78.353% |
| PAVmed Inc | 64.82 Million USD | 84.094% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 79.813% |
| RxSight, Inc. | 103.85 Million USD | 90.071% |
| Sight Sciences, Inc. | 126.44 Million USD | 91.846% |
| SI-BONE, Inc. | 156.35 Million USD | 93.405% |
| TELA Bio, Inc. | 84.18 Million USD | 87.752% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 85.281% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 94.93% |
| LivaNova PLC | 843.54 Million USD | 98.778% |
| 908 Devices Inc. | 68.08 Million USD | 84.854% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 97.868% |
| Nemaura Medical Inc. | 7.13 Million USD | -44.439% |
| NeuroPace, Inc. | 75.29 Million USD | 86.306% |
| LENSAR, Inc. | 33.33 Million USD | 69.069% |
| Apyx Medical Corporation | 51.01 Million USD | 79.789% |
| Cutera, Inc. | 197.72 Million USD | 94.785% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 58.391% |
| BioSig Technologies, Inc. | 28.53 Million USD | 63.858% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 94.615% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 71.405% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 98.767% |
| Axonics, Inc. | 270.2 Million USD | 96.184% |
| Outset Medical, Inc. | 198.77 Million USD | 94.812% |
| IRIDEX Corporation | 31.81 Million USD | 67.589% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 94.279% |
| IRadimed Corporation | 30.12 Million USD | 65.769% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -20.853% |
| INVO Bioscience, Inc. | 7.85 Million USD | -31.298% |
| Telesis Bio, Inc. | 63.48 Million USD | 83.759% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 89.527% |
| Varex Imaging Corporation | 224.8 Million USD | 95.413% |
| Quipt Home Medical Corp. | 148.66 Million USD | 93.064% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 12.043% |
| Pulmonx Corporation | 112.68 Million USD | 90.85% |
| Dynatronics Corporation | 9.9 Million USD | -4.069% |
| Modular Medical, Inc. | 17.52 Million USD | 41.176% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 48.922% |
| Semler Scientific, Inc. | 38.94 Million USD | 73.523% |
| InMode Ltd. | 215.68 Million USD | 95.219% |
| Bruker Corporation | 1.07 Billion USD | 99.042% |
| Cytosorbents Corporation | 48.33 Million USD | 78.668% |
| DexCom, Inc. | 1.69 Billion USD | 99.39% |
| Align Technology, Inc. | 2.07 Billion USD | 99.504% |
| Viveve Medical, Inc. | 22.17 Million USD | 53.497% |
| ZimVie Inc. | 275.12 Million USD | 96.252% |
| Movano Inc. | 29.69 Million USD | 65.27% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 92.488% |
| Nexalin Technology, Inc. | 5.78 Million USD | -78.353% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -192.268% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 98.284% |
| Profound Medical Corp. | 33.6 Million USD | 69.315% |
| Insulet Corporation | 939.9 Million USD | 98.903% |
| enVVeno Medical Corporation | 25.23 Million USD | 59.144% |
| Surmodics, Inc. | 98.69 Million USD | 89.553% |
| iCAD, Inc. | 22.22 Million USD | 53.605% |
| Nuwellis, Inc. | 22.61 Million USD | 54.401% |
| Biotricity, Inc. | 17.18 Million USD | 39.997% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 97.687% |
| Aethlon Medical, Inc. | 12.27 Million USD | 16.015% |
| InspireMD, Inc. | 22.95 Million USD | 55.071% |
| PAVmed Inc. | 64.82 Million USD | 84.094% |
| BIOLASE, Inc. | 34.66 Million USD | 70.251% |
| Beyond Air, Inc. | 61.7 Million USD | 83.288% |
| FONAR Corporation | 28.6 Million USD | 63.953% |
| AxoGen, Inc. | 149.33 Million USD | 93.095% |
| Vivani Medical, Inc. | 26.96 Million USD | 61.761% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 94.177% |
| Inari Medical, Inc. | 448.59 Million USD | 97.701% |
| UFP Technologies, Inc. | 58.08 Million USD | 82.249% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -109.254% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -63.196% |
| Tenon Medical, Inc. | 16.96 Million USD | 39.231% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -39.473% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 76.62% |
| AdaptHealth Corp. | 1.07 Billion USD | 99.043% |
| Sintx Technologies, Inc. | 15.2 Million USD | 32.168% |
| NanoVibronix, Inc. | 4.97 Million USD | -107.344% |
| Quanterix Corporation | 118.1 Million USD | 91.269% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 12.043% |
| Sensus Healthcare, Inc. | 14.44 Million USD | 28.603% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 97.374% |
| TransMedics Group, Inc. | 182.82 Million USD | 94.36% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 63.26% |
| NeuroMetrix, Inc. | 11.09 Million USD | 7.097% |
| Hyperfine, Inc. | 52.87 Million USD | 80.498% |
| Establishment Labs Holdings Inc. | 172 Million USD | 94.005% |
| Biomerica, Inc. | 6.97 Million USD | -47.767% |
| Bone Biologics Corporation | 9.42 Million USD | -9.364% |
| AVITA Medical, Inc. | 80.77 Million USD | 87.235% |
| Silk Road Medical, Inc | 186.35 Million USD | 94.467% |